Skip to main content
Psych Capital Plc logo

Psych Capital Plc — Investor Relations & Filings

Ticker · PSY ISIN · GB00BL6CJQ54 LEI · 213800WXCQ1C6GPLHH68 IL Professional, scientific and technical activities
Open in API
Filings indexed 61 across all filing types
Latest filing 2026-05-22 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PSY

About Psych Capital Plc

https://psych.capital/

Shortwave Life Sciences Plc, formerly Psych Capital Plc, is a biopharmaceutical company that originates and develops innovative treatments for mental healthcare. The company's primary clinical program focuses on developing a psilocybin-based therapy for anorexia nervosa, a condition with no currently approved medication. It employs an IP-driven approach, leveraging global partnerships and an experienced leadership team to optimize its drug discovery and development processes. Through its subsidiary, Blossom Analysis, the company also provides a data and insights platform for the psychedelic healthcare industry.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 95% confidence The document is a TR-1 standard form notifying a person’s crossing of a voting rights threshold (5.78% holding) under DTR, which is a notification of a major shareholding. This matches the “Major Shareholding Notification” category (Code: MRQ).
2026-05-22 English
Name Change, Board Change and Company Update
Regulatory Filings Classification · 82% confidence The document is an RNS announcement combining multiple corporate updates: a name change, fundraising progress (capital structure update), board resignation (management change), advisor appointments, director options grants, and total voting rights disclosure. It does not present detailed financial statements (so not an Annual or Interim Report), nor is it a standalone earnings release, proxy statement, or specialized ESG or M&A filing. It is a standard regulatory announcement for the London Stock Exchange’s RNS service and thus falls into the generic “Regulatory Filings” category.
2026-05-18 English
Total Voting Rights & Update of Fundraising
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shortwave Life Sciences Plc dated 30 April 2026. It provides an update on the company's fundraising activities and total voting rights following the admission of new securities. The text includes details about a subscription agreement, placing of new shares, the total number of ordinary shares in issue, and voting rights. It does not contain financial statements or detailed financial analysis but rather informs shareholders and the market about recent capital raising and share count changes. The document is relatively short (3127 characters) and serves as a regulatory announcement about fundraising and voting rights, fitting the Capital/Financing Update (CAP) category rather than a full financial report or other types of filings.
2026-04-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 93% confidence The document is a completed Standard TR-1 Form for notification of major holdings in accordance with FCA Disclosure Guidance and Transparency Rules Chapter 5. It reports that Steve Xerri has crossed the 3% threshold to hold 6.4% of voting rights in Shortwave Life Sciences PLC. This is exactly a Major Shareholding Notification.
2026-04-24 English
BOARD APPOINTMENT, FUND RAISE & OPTION AGREEMENTS
Board/Management Information Classification · 88% confidence The document is an RNS announcement covering the immediate resignation and appointment of board directors (Mr. Ron Lipsky stepping down and Mr. Keith Coughlan joining) as its lead items. While it also includes fundraising details and option agreements, the primary headline and focus is on board changes, making it a Board/Management Information filing under our taxonomy.
2026-04-20 English
Interim Results to 31 October 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Interim Results for the Six Months Ended 31 October 2025' and contains comprehensive financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows. It provides a detailed financial review and management commentary for a period shorter than a full fiscal year. It is not merely an announcement of a report, but the report itself, containing substantive financial data. H1 2025
2026-01-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.